2lhemelandu C U, Leffall L D Jr, Dewitty R L, et al. Molecular breast cancer subtypes in premenopansal and postmenopausal Afri- can-American women : age-specific prevalence and survival [ J ]. J Surg Res, 2007,143(1) :109 -18.
3Stefansson 0 A, Jonasson J G, Johannsson 0 T, et al. Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes[ J]. Breast Cancer Res, 2009,11 (4) :R47.
4Sener S F, Winchester D J, Winchester D P, et al. The effects of hormone replacement therapy on postmenopausal breast cancer bi- ology and survival[ J ]. Am J Surg, 2009,197 ( 3 ) :403 - 7.
5Buckley N E, Conlon S J, Jirstrom K, et al. The DehaNp63 pro- teins are key allies of BRCA1 in the prevention of basaMike breast cancer[J]. Cancer Res, 2011 ,71 (5) :1933 -44.
7Mani6 E, Vincent-Salomon A, Lehmann-Che J, et al. High fre- quency of TP53 mutation in BRCA1 and sporadic basal-like carci- nomas but not in BRCA1 luminal breast tumors[J]. Cancer Res, 200969(2) :663 -71.
8Graveel C R, DeGroot J D, Su Y, et al. Met induces diverse mammary carcinomas in mice and is associated with human basal breast cancer [ J]. Proc Natl Acad Sci USA, 2009,106 ( 31 ) : 12909 - 14.
10Xu K, Usary J, Kousis P C, et al. Lunatic fringe deficiency coop- erates with the Met/Caveolin gene amplicon to induce basal-like breast cancer[ J]. Cancer Cell, 2012,2t (5) :626 -41.
7Fong PC, Boss DS, Yap TA, et al. Inhibition of poly (ADP-ribose) polymerase in tumors from BRCA mutation carriers[J ]. N Engl J Med, 2009,361(2) : 123-134.
8Dong F,Soubeyrand S,Hache RJ. Citivation of PARP-I in response to bleomycin depends on the Ku antigen and protein phosphatase 5 [ J ]. Oncogene, 2010,29 ( 14 ) : 2093-2103.
9Donawho CK,Luo Y,Luo Y,et al. ABT-888,an orally active poly (ADP-ribose)polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor models[ J ]. Clin Cancer Res,2007,13(9) : 2728-2737.
10King M C, Marks J H, Mandell J B, et al. Breast and ovarian cancer risks due to inherited mutations in BRCAI and BRCA2 [J ]. Science, 2003,302 (5645) : 643-646.
2Schouten PC, Marine F, Aulmann S, et al. Breast cancer with BRCAI-like DNA copy number profile recur less often than expectec after high-dose alkylating chemotherapy[J].Clin Cancer Res, 2014. [ Epub ahead of print].
3Levanat S, Musani V, Cvok ML, et al. Three novel BRCA1/BRCA2 mutations in breast/ovarian cancer families in Croatia[J].Gene, 2012,498 ( 2 ) : 169 - 176.
